Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia
Year: 2007
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: European Heart Journal
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: darbepoetin alfa, chronic heart failure, anemia, erythropoiesis-stimulating agents, dosing regimen, weight-based dosing, fixed dose, hemoglobin response, 6-minute walk distance, NYHA functional class, Kansas City Cardiomyopathy Questionnaire, quality of life, left ventricular ejection fraction, patient safety, adverse events
Open Access status: closed
Funder: Amgen
OpenAlex ID: W2164945887
